US Stock MarketDetailed Quotes
MSLPQ MusclePharm
- 0.000001
- 0.0000000.00%
15min DelayTrading Apr 18 16:00 ET
34.35Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000001Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)34.35MShares0.09450052wk High0.00P/B12.32Float Cap0.00000152wk Low--Dividend TTM12.32MShs Float0.094500Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low--Avg Price1Lot Size
MusclePharm Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | (Q3)Sep 30, 2020 | (Q2)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.15%13.1M | -22.34%50.04M | -33.63%10.04M | -25.58%11.97M | -12.27%14.91M | -19.16%13.12M | -19.11%64.44M | -13.13%15.13M | -24.04%16.09M | -23.79%16.99M |
| Operating revenue | -0.15%13.1M | -22.34%50.04M | -33.63%10.04M | -25.58%11.97M | -12.27%14.91M | -19.16%13.12M | -19.11%64.44M | -13.13%15.13M | -24.04%16.09M | -23.79%16.99M |
| Cost of revenue | 22.90%11.59M | -0.36%44.67M | 2.34%10.57M | 7.85%11.94M | 5.99%12.73M | -17.42%9.43M | -36.84%44.83M | -30.70%10.33M | -43.65%11.07M | -41.63%12.01M |
| Gross profit | -59.09%1.51M | -72.61%5.37M | -110.97%-527K | -99.42%29K | -56.26%2.18M | -23.29%3.69M | 125.70%19.61M | 90.94%4.8M | 228.44%5.01M | 188.76%4.98M |
| Operating expense | 16.74%3.99M | -15.18%14.28M | -6.93%3.48M | -17.68%3.47M | -15.34%3.92M | -19.75%3.42M | -29.23%16.84M | -30.45%3.74M | -25.01%4.21M | -29.36%4.63M |
| Selling and administrative expenses | 16.74%3.99M | -15.18%14.28M | -6.93%3.48M | -17.68%3.47M | -15.34%3.92M | -19.75%3.42M | -29.23%16.84M | -30.45%3.74M | -25.01%4.21M | -29.36%4.63M |
| -Selling and marketing expense | 0.96%1.16M | 12.99%4.39M | -33.00%1.2M | 62.44%1.01M | -22.87%145K | 819.20%1.15M | 56.33%3.89M | 406.52%1.79M | 8.54%623K | -76.76%188K |
| -General and administrative expense | 24.74%2.83M | -23.63%9.89M | 16.97%2.28M | -31.60%2.45M | -15.02%3.78M | -45.12%2.27M | -39.22%12.95M | -61.16%1.95M | -28.84%3.59M | -22.69%4.45M |
| Operating profit | -1,011.76%-2.48M | -421.89%-8.91M | -476.24%-4.01M | -527.90%-3.44M | -598.00%-1.74M | -50.64%272K | 118.33%2.77M | 137.24%1.07M | 119.65%803K | 107.24%350K |
| Net non-operating interest income expense | -649.22%-3.82M | -265.71%-5.46M | -1,064.89%-3.63M | -7.22%-683K | -0.95%-640K | 14.72%-510K | 55.74%-1.49M | 163.73%376K | 30.15%-637K | 30.02%-634K |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | -47.26%202K | ---- | ---- | ---- |
| Non-operating interest expense | 25.10%638K | 57.29%2.67M | 579.31%834K | 7.22%683K | 0.95%640K | -14.72%510K | -54.87%1.7M | -124.54%-174K | -35.33%637K | -36.41%634K |
| Total other finance cost | --3.18M | --2.79M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other net income (expense) | -13.12%1.64M | -26.39%954K | -59.02%218K | 162.26%139K | 3,588.89%332K | 623.55%1.89M | 10,900.00%1.3M | 2,070.37%532K | 144.92%53K | |
| Gain on sale of security | ---- | -250.00%-28K | -516.67%-50K | -400.00%-10K | 112.50%34K | ---- | 96.61%-8K | 200.00%12K | 81.82%-2K | 223.08%16K |
| Special income (charges) | ---- | 677.84%965K | --965K | --0 | ---- | ---- | ---167K | --0 | ---167K | ---- |
| -Less:Impairment of capital assets | ---- | --0 | --0 | --0 | ---- | ---- | --167K | --0 | --167K | ---- |
| -Less:Other special charges | ---- | ---965K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | ---- | -65.86%705K | -96.96%39K | -67.48%228K | 183.78%105K | 672.09%332K | 1,752.00%2.07M | --1.28M | 4,481.25%701K | 135.24%37K |
| Income before tax | -6,803.19%-6.3M | -506.63%-12.87M | -349.32%-6.82M | -658.88%-3.9M | -871.43%-2.24M | 347.37%94K | 116.80%3.17M | 179.06%2.74M | 113.89%698K | 96.06%-231K |
| Income tax | 57.89%-8K | 42.17%-48K | 60.00%32K | -68.18%7K | -122.09%-19K | -2,666.67%-83K | -62.26%20K | -15.38%22K | ||
| Net income | -6,803.19%-6.3M | -503.96%-12.87M | -340.28%-6.78M | -680.09%-3.93M | -789.72%-2.25M | 256.67%94K | 116.83%3.19M | 181.53%2.82M | 113.35%678K | 95.70%-253K |
| Net income continuous Operations | -6,803.19%-6.3M | -503.96%-12.87M | -340.28%-6.78M | -680.09%-3.93M | -789.72%-2.25M | 256.67%94K | 116.83%3.19M | 181.53%2.82M | 113.35%678K | 95.70%-253K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -6,803.19%-6.3M | -503.96%-12.87M | -340.28%-6.78M | -680.09%-3.93M | -789.72%-2.25M | 256.67%94K | 116.83%3.19M | 181.53%2.82M | 113.35%678K | 95.70%-253K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -6,803.19%-6.3M | -503.96%-12.87M | -340.28%-6.78M | -680.09%-3.93M | -789.72%-2.25M | 256.67%94K | 116.83%3.19M | 181.53%2.82M | 113.35%678K | 95.70%-253K |
| Basic earnings per share | -6,794.86%-0.19 | -490.00%-0.39 | -322.22%-0.2 | -700.00%-0.12 | -600.00%-0.07 | 253.57%0.0028 | 110.87%0.1 | 185.86%0.09 | 107.41%0.02 | 97.37%-0.01 |
| Diluted earnings per share | -9,296.52%-0.19 | -587.50%-0.39 | -433.33%-0.2 | -1,300.00%-0.12 | -600.00%-0.07 | 211.80%0.0021 | 108.70%0.08 | 157.24%0.06 | 103.70%0.01 | 97.37%-0.01 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg